Latest debt-to-equity ratio
Aytu BioPharma Debt-to-equity ratio
Direct answer
Aytu BioPharma's debt-to-equity ratio is 51.33%.
The verified market snapshot reports 51.33%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free Aytu BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 51.33%
Explore related company data
View Aytu BioPharma's market capitalizationView Aytu BioPharma's price-to-book ratioView Aytu BioPharma's return on equityView Aytu BioPharma's dividend yieldView Aytu BioPharma's 52-week price rangeView Aytu BioPharma's revenue growthView Aytu BioPharma's profit marginView all Aytu BioPharma key metricsReturn to Aytu BioPharma profile